Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
8.92
-0.13 (-1.38%)
At close: May 15, 2025, 4:00 PM
8.91
0.00 (-0.06%)
After-hours: May 15, 2025, 4:43 PM EDT
Adaptive Biotechnologies Stock Forecast
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for Adaptive Biotechnologies stock ranges from a low of $6.00 to a high of $13. The average analyst price target of $9.83 forecasts a 10.26% increase in the stock price over the next year.
Price Target: $9.83 (+10.26%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Adaptive Biotechnologies stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $11 → $13 | Buy | Maintains | $11 → $13 | +45.82% | May 6, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $7 → $9 | Hold | Maintains | $7 → $9 | +0.95% | May 5, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +12.17% | May 2, 2025 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $8 → $9 | Hold → Strong Buy | Upgrades | $8 → $9 | +0.95% | Mar 21, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $7 → $11 | Buy | Reiterates | $7 → $11 | +23.39% | Feb 20, 2025 |
Financial Forecast
Revenue This Year
222.82M
from 178.96M
Increased by 24.51%
Revenue Next Year
269.30M
from 222.82M
Increased by 20.86%
EPS This Year
-0.94
from -1.08
EPS Next Year
-0.71
from -0.94
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 237.2M | 293.2M | 369.2M | |
| Avg | 222.8M | 269.3M | 335.9M | |
| Low | 203.4M | 237.7M | 304.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 32.6% | 31.6% | 37.1% | |
| Avg | 24.5% | 20.9% | 24.7% | |
| Low | 13.6% | 6.7% | 12.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.87 | -0.60 | -0.29 |
| Avg | -0.94 | -0.71 | -0.40 |
| Low | -1.02 | -0.93 | -0.46 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.